Bortezomib - redOrbit

Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting

2012-05-16 02:29:59

( ) ( ) ( ) SOUTH SAN FRANCISCO, Calif., May 16, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc.

Aeterna Zentaris Regains North American Rights for Perifosine from Keryx

2012-05-07 02:32:00

Aeterna Zentaris to continue ongoing Phase 3 trial in multiple myeloma QUEBEC CITY, May 7, 2012 /PRNewswire/ - Aeterna Zentaris Inc.

Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting

2012-03-29 02:25:43

CALGARY, March 29, 2012 /PRNewswire/ - Oncolytics Biotech Inc.

Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma

2012-02-22 15:30:00

Phase 3 Trial DesignThe ASPIRE (CArfilzomib, Lenalidomide, and DexamethaSone versus Lenalidomide and Dexamethasone for the treatment of PatIents with Relapsed Multiple MyE

Pharmacyclics Reports Fiscal 2012 Second Quarter Financial Results

2012-02-09 05:30:00

SUNNYVALE, Calif., Feb. 9, 2012 /PRNewswire/ -- Pharmacyclics, Inc.

News - Bortezomib

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health